Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in periorbital oculoplastic surgery
NCT05672407Phase 4Withdrawn
- Sponsor
- University of Miami
- Start
- Sep 2023
- Primary completion
- Jun 2026
- Modality
- Small Molecules
01
Overview
Phase 4, randomised trial in hemorrhage comparing Tranexamic Acid Group with Placebo Group (2 arms). Primary endpoint: Postoperative patient ecchymosis at 3 months. Planned start Sep 2023; status: withdrawn.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT05672407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05672407.